Former FDA Commissioner Scott Gottlieb, MD, emphasized testing, contact tracing, and treatment to address coronavirus disease 2019 (COVID-19); US pediatric practices have struggled during the pandemic; FDA approves first saliva-based coronavirus test.
In advising lawmakers, governors, and members of the Trump administration on how to return to normalcy amid the economic lockdown caused by the coronavirus disease 2019 (COVID-19), former FDA Commissioner Scott Gottlieb emphasized the importance of 3 T’s: testing, contact tracing, and treatment. Reported in The Washington Post, Gottlieb noted that if business leaders are seeking to reopen state economies, companies should reduce potential risks to their employees and society by providing rapid COVID-19 tests at work and guaranteeing sick leave for those infected.
Reported in Kaiser Health News, thousands of pediatric practices that provide front-line care for US children have been struggling to adapt to the COVID-19 pandemic, which has caused significant loss of revenue and shortages of protective equipment. Berkeley Pediatrics, a 78-year-old practice in Berkeley, California, noted that patient volume has dropped nearly 60% since San Francisco Bay Area officials issued the first shelter-in-place order. With the office scrambling to set up telehealth services for sick visits, 6 physicians have already been laid off, and all have taken a 40% pay cut.The first saliva-based coronavirus test, from the Rutgers University lab RUCDR Infinite Biologics, was issued emergency-use authorization by the FDA Monday and will be available through hospitals and clinics associated with the university, according to The Associated Press. As opposed to current testing which requires samples from a patient’s nose or throat, patients will spit in a tube several times to provide the sample. Andrew Brooks, who directs the Rutgers lab, highlighted that the test “prevents health care professionals from having to actually be in the face of somebody that is symptomatic.”
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
2 Commerce Drive
Cranbury, NJ 08512